These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16293001)

  • 1. Inflammation in coronary artery disease: potential role for immunomodulatory therapy.
    Aukrust P; Yndestad A; Waehre T; Gullestad L; Halvorsen B; Damås JK
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1111-24. PubMed ID: 16293001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines in cardiovascular risk prediction.
    Aukrust P; Yndestad A; Smith C; Ueland T; Gullestad L; Damås JK
    Thromb Haemost; 2007 May; 97(5):748-54. PubMed ID: 17479185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation.
    Aukrust P; Yndestad A; Smith C; Sandberg WJ; Ueland T; Waehre T; Halvorsen B; Gullestad L; Damås JK
    Expert Opin Pharmacother; 2005 Oct; 6(13):2169-80. PubMed ID: 16218879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulation.
    Wilensky RL; Hamamdzic D
    Curr Opin Cardiol; 2007 Nov; 22(6):545-51. PubMed ID: 17921743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
    Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in coronary artery diseases.
    Li JJ
    Chin Med J (Engl); 2011 Nov; 124(21):3568-75. PubMed ID: 22340179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying the vulnerable patient with rupture-prone plaque.
    Weintraub HS
    Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines as therapeutic targets for atherosclerotic plaque destabilization and rupture.
    Daissormont IT; Kraaijeveld AO; Biessen EA
    Future Cardiol; 2009 May; 5(3):273-84. PubMed ID: 19450053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines and cardiovascular risk.
    Aukrust P; Halvorsen B; Yndestad A; Ueland T; Øie E; Otterdal K; Gullestad L; Damås JK
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1909-19. PubMed ID: 18669888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
    Jurcuţ C; Jurcuţ R; Tănăsescu C
    Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature atherosclerotic disease in systemic lupus erythematosus--role of inflammatory mechanisms.
    Rhew EY; Ramsey-Goldman R
    Autoimmun Rev; 2006 Feb; 5(2):101-5. PubMed ID: 16431336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
    Zambon A; Gervois P; Pauletto P; Fruchart JC; Staels B
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):977-86. PubMed ID: 16424352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of monocytes in atherosclerotic coronary artery disease.
    Pamukcu B; Lip GY; Devitt A; Griffiths H; Shantsila E
    Ann Med; 2010 Sep; 42(6):394-403. PubMed ID: 20568979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy for coronary heart disease: the myth and the reality.
    Kuppuswamy VC; Gupta S
    Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E2. PubMed ID: 16404482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The two faces of the 15-lipoxygenase in atherosclerosis.
    Wittwer J; Hersberger M
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):67-77. PubMed ID: 17869078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view.
    Ridker PM
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S9-12. PubMed ID: 10070810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory strategies in coronary atherosclerosis.
    Burton PB; Daniel TO
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1725-8. PubMed ID: 12528306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, atherosclerosis, and stroke.
    Elkind MS
    Neurologist; 2006 May; 12(3):140-8. PubMed ID: 16688015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines in development to prevent and treat atherosclerotic disease.
    Riley E; Dasari V; Frishman WH; Sperber K
    Cardiol Rev; 2008; 16(6):288-300. PubMed ID: 18923232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of inflammation in coronary artery calcification.
    Li JJ; Zhu CG; Yu B; Liu YX; Yu MY
    Ageing Res Rev; 2007 Dec; 6(4):263-70. PubMed ID: 17964226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.